v3.26.1
Unaudited Condensed Consolidated Statements of Shareholders' Equity - USD ($)
$ in Thousands
Total
Series A Preferred Stock
Preferred Stock
Series A Preferred Stock
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning balance, preferred stock, outstanding (in shares) at Dec. 31, 2024     0        
Beginning balance at Dec. 31, 2024 $ 348,909   $ 0 $ 47 $ 683,939 $ 24 $ (335,101)
Beginning balance, common stock, outstanding (in shares) at Dec. 31, 2024       46,906,765      
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Stock-based compensation $ 10,012       10,012    
Stock option exercises (in shares) 10,000     10,000      
Stock option exercises $ 18       18    
Stock issued – on vested shares (in shares)       715,713      
Stock issued – on vested shares 0     $ 1 (1)    
Common stock shares issued for PanTHERA Transaction (in shares)       213,360      
Common stock shares issued for PanTHERA Transaction 4,455       4,455    
Unrealized (loss) gain on available-for-sale securities 47         47  
Net income (loss) (16,286)           (16,286)
Ending balance, preferred stock, outstanding (in shares) at Jun. 30, 2025     0        
Ending balance at Jun. 30, 2025 347,155   $ 0 $ 48 698,423 71 (351,387)
Ending balance, common stock, outstanding (in shares) at Jun. 30, 2025       47,845,838      
Beginning balance, preferred stock, outstanding (in shares) at Mar. 31, 2025     0        
Beginning balance at Mar. 31, 2025 352,624   $ 0 $ 48 688,092 33 (335,549)
Beginning balance, common stock, outstanding (in shares) at Mar. 31, 2025       47,548,431      
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Stock-based compensation 5,859       5,859    
Stock option exercises (in shares)       10,000      
Stock option exercises 18       18    
Stock issued – on vested shares (in shares)       74,047      
Stock issued – on vested shares (1)       (1)    
Common stock shares issued for PanTHERA Transaction (in shares)       213,360      
Common stock shares issued for PanTHERA Transaction 4,455       4,455    
Unrealized (loss) gain on available-for-sale securities 38         38  
Net income (loss) (15,838)           (15,838)
Ending balance, preferred stock, outstanding (in shares) at Jun. 30, 2025     0        
Ending balance at Jun. 30, 2025 347,155   $ 0 $ 48 698,423 71 (351,387)
Ending balance, common stock, outstanding (in shares) at Jun. 30, 2025       47,845,838      
Beginning balance, preferred stock, outstanding (in shares) at Dec. 31, 2025   0 0        
Beginning balance at Dec. 31, 2025 $ 371,888   $ 0 $ 48 711,404 132 (339,696)
Beginning balance, common stock, outstanding (in shares) at Dec. 31, 2025 48,198,928     48,198,928      
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Stock-based compensation $ 8,660       8,660    
Stock option exercises (in shares) 102,000     102,000      
Stock option exercises $ 193       193    
Stock issued – on vested shares (in shares)       891,080      
Stock issued – on vested shares 0     $ 1 (1)    
Tax withholding on vesting of RSUs (in shares)       (302,918)      
Tax withholding on vesting of shares (6,685)       (6,685)    
Unrealized (loss) gain on available-for-sale securities (343)         (343)  
Net income (loss) 46,290           46,290
Ending balance, preferred stock, outstanding (in shares) at Jun. 30, 2026   0 0        
Ending balance at Jun. 30, 2026 $ 420,003   $ 0 $ 49 713,571 (211) (293,406)
Ending balance, common stock, outstanding (in shares) at Jun. 30, 2026 48,889,090     48,889,090      
Beginning balance, preferred stock, outstanding (in shares) at Mar. 31, 2026     0        
Beginning balance at Mar. 31, 2026 $ 372,230   $ 0 $ 49 710,811 (120) (338,510)
Beginning balance, common stock, outstanding (in shares) at Mar. 31, 2026       48,825,291      
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Stock-based compensation 3,854       3,854    
Stock option exercises (in shares)       2,000      
Stock option exercises 3       3    
Stock issued – on vested shares (in shares)       92,620      
Tax withholding on vesting of RSUs (in shares)       (30,821)      
Tax withholding on vesting of shares (1,097)       (1,097)    
Unrealized (loss) gain on available-for-sale securities (91)         (91)  
Net income (loss) 45,104           45,104
Ending balance, preferred stock, outstanding (in shares) at Jun. 30, 2026   0 0        
Ending balance at Jun. 30, 2026 $ 420,003   $ 0 $ 49 $ 713,571 $ (211) $ (293,406)
Ending balance, common stock, outstanding (in shares) at Jun. 30, 2026 48,889,090     48,889,090